Shire takeover may take months to finish - The Boston Globe
Takeda-Shire deal: the strategy behind Japan's largest foreign acquisition - Pharmaceutical Technology
Shire plc
SHP647 may take a back seat to Entyvio after Takeda-Shire merger
Massive Takeda Pharma buyout of Shire a high-risk move with uncertain rewards - The Mainichi
After profits dip Takeda may find solace in Shire merger, says GlobalData - European Pharmaceutical Manufacturer
Shire, AbbVie unveil $54 billion merger
Shire rejects £42.4bn Takeda offer as Allergan rules itself out | Financial Times
Takeda and Shire Agree Merger Terms | CHEManager
Takeda takes biggest gamble of 2018 with Shire merger -
Takeda Pharmaceutical Agrees $62.4 Billion Takeover of Shire - TheStreet
Takeda finally snags Shire in $62 billion deal
Takeda and Shire finally agree takeover terms after months of negotiations – The New Economy
News Release
Shire agrees $32bn takeover of Baxalta | Financial Times
Takeda Pharmaceutical and Shire receive shareholders' approval for Takeda- Shire deal | AlphaStreet
Takeda Acquisition Of Shire Officially Closes, CEO Christophe Weber Shares His Plans For The Future
Takeda to sell nearly new Shire plant with 200 employees | Fierce Pharma
Takeda shunts jewel of Shire takeover to new spinoff Oak Hill | Fierce Biotech
Japan drug giant Takeda tumbles as Shire recommends $64 bn offer
Reviewing The Takeda-Shire Merger (NASDAQ:SHPG) | Seeking Alpha
Takeda breaks into top 20 largest pharmas with Shire merger | Pharmaphorum
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WO
